Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 45 out of 100. Prevention trials

Topic: Risk, prevention and care in population studies

Assistive technology (AT) involvement in therapeutic treatment has provided simple and efficient healthcare solutions to people. Within a short span of time, mobile health (mHealth) has grown rapidly for assisting people living with a chronic disorder. This research paper presents the comprehensive study to identify and review existing mHealth dementia applications (apps), and also synthesize the evidence of using these applications in assisting people with dementia including Alzheimer's disease (AD) and their caregivers. Six electronic databases searched with the purpose of finding literature-based evidence. The search yielded 2818 research articles, with 29 meeting quantified inclusion and exclusion criteria. Six groups and their associated sub-groups emerged from the literature. The main groups are (1) activities of daily living (ADL) based cognitive training, (2) monitoring, (3) dementia screening, (4) reminiscence and socialization, (5) tracking, and (6) caregiver support. Moreover, two commercial mobile application stores i.e., Apple App Store (iOS) and Google Play Store (Android) explored with the intention of identifying the advantages and disadvantages of existing commercially available dementia and AD healthcare apps. From 678 apps, a total of 38 mobile apps qualified as per defined exclusion and inclusion criteria. The shortlisted commercial apps generally targeted different aspects of dementia as identified in research articles. This comprehensive study determined the feasibility of using mobile Health based applications for dementia including AD individuals and their caregivers regardless of limited available research, and these apps have capability to incorporate a variety of strategies and resources to dementia community care.

Key findings

Study details

How this study scored 45/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 2 of 5; Sample size 1 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 2 of 2; Free to read 0 of 2. 26 of the 58 points it could be judged on, which is 45 of 100. Total 45 of 100.26 of the 58 points we could judge = 45 of 100

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 26 of the 58 points we could judge it on, which is 45 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Health care management science)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 2 / 5 2020 — within 10 year(s) of the newest study here
Sample size 1 / 4 38 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 31218511)
Free to read 0 / 2 Behind a paywall — scores zero
Points 26 / 58 Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 26 of the 58 points we could judge it on is 45 out of 100.
Total 45 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Yousaf, K., Mehmood, Z., Awan, I. A., Saba, T., Alharbey, R., Qadah, T., et al. (2020). A comprehensive study of mobile-health based assistive technology for the healthcare of dementia and Alzheimer's disease (AD). Health care management science. https://doi.org/10.1007/s10729-019-09486-0

Vancouver

Yousaf K, Mehmood Z, Awan IA, Saba T, Alharbey R, Qadah T, et al. A comprehensive study of mobile-health based assistive technology for the healthcare of dementia and Alzheimer's disease (AD). Health care management science. 2020. doi:10.1007/s10729-019-09486-0. PMID: 31218511.

BibTeX

@article{yousaf2020-31218511,
  author  = {Yousaf, K. and Mehmood, Z. and Awan, I. A. and Saba, T. and Alharbey, R. and Qadah, T. and Alrige, M. A.},
  title   = {{A comprehensive study of mobile-health based assistive technology for the healthcare of dementia and Alzheimer's disease (AD)}},
  journal = {Health care management science},
  year    = {2020},
  doi     = {10.1007/s10729-019-09486-0},
  pmid    = {31218511},
  url     = {https://doi.org/10.1007/s10729-019-09486-0}
}

Related studies in Prevention trials

Also in Prevention trials

86 studies in the library are filed under Prevention trials with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Prevention trials hub.

Similar studies

More on Prevention trials

See all studies in Prevention trials →